Zobrazeno 1 - 10
of 580
pro vyhledávání: '"J. Hilgers"'
Publikováno v:
Journal of clinical orthodontics : JCO. 53(11)
Autor:
U. Töx, KJ Lackner, M Warm, M. Zähringer, C. Bangard, K. Krüger, D. Strohe, M Reiser, J. Hilgers, L. Neumann
Publikováno v:
RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren. 178:324-329
PURPOSE: Retrospective analysis of the success and complication rates of chest port implantation via the lateral subclavian vein. MATERIALS AND METHODS: Between January 2003 and June 2004, the lateral subclavian vein in 271 patients (186 women, 85 me
Autor:
Allan G. Farman, Michael J. Hilgers, Mazyar Moshiri, William C. Scarfe, Oana Bida, Predrag Sukovic
Publikováno v:
International Congress Series. 1281:1187-1190
Cone-beam computed tomography (CBCT) systems dedicated to craniofacial imaging are now available from several different manufacturers. Potentially, CBCT will permit the use of 3D cephalometrics for orthodontic assessment. A simple method is demonstra
Autor:
J. J. Hilgers
Publikováno v:
Informationen aus Orthodontie & Kieferorthopädie. 37:177-184
Autor:
F.G.M. Snijdewint, J. J. Oudejans, Roelof Willemze, J. Hilgers, Ria J.J. Poort-Keesom, S von Mensdorff-Pouilly, J W R Meijer, C. J. L. M. Meijer, R L ten Berge
Publikováno v:
Journal of Clinical Pathology. 54:933-939
Aims—To investigate whether MUC1 mucin, a high molecular weight transmembrane glycoprotein, also known as epithelial membrane antigen (EMA), differs in its expression and degree of glycosylation between anaplastic large cell lymphoma (ALCL) and cla
Autor:
E. Wiebelhaus, P. Seguin, J.F. Leca, B.E. Sundström, H. Bodenmüller, L. Bellanger, T. Meier, M. Nap, B. Wiklund, C. Andrés, J. Hilgers, H. Bonfrer, A. van Dalen, A. Sjödin, Anders Johansson, Ann Erlandsson, T. van Wel, J. Brundell, Torgny Stigbrand, R. Einarsson
Publikováno v:
Tumor Biology. 22:4-10
In the first report of the TD5 workshop (TD5-1), the epitope specificities of 30 different monoclonal antibodies against cytokeratins 8, 18 and 19 were determined. This second report presents the immunohistochemical profiles of these antibodies using
Publikováno v:
Head & neck, 23(5), 372-375. John Wiley and Sons Inc.
Background The role of pain in head and neck cancer is seldom addressed. This retrospective study examined in a group of 190 curatively treated patients to what extent pain complaints should be considered to be the first sign of recurrent disease. Me
Autor:
Joy Burchell, Stéphane Paul, Jean-Marc Balloul, K Dott, Joyce Taylor-Papadimitriou, Michel Geist, Marie-Paule Kieny, David Snary, J Hilgers, Johan Hoebeke, Nadine Bizouarne, D. Allen, R B Acres
Publikováno v:
Human Gene Therapy. 11:1417-1428
Antigen-specific recognition and subsequent destruction of tumor cells is the goal of vaccine-based immunotherapy of cancer. Often, however, tumor antigen-specific cytotoxic T lymphocytes (CTLs) are either not available or in a state of anergy. In ad
Autor:
Michael R. Price, F.G.M. Snijdewint, A.A. Verstraeten, Kees van Uffelen, Peter Kenemans, J. Hilgers, Celso A. Reis, Eftichia Petrakou, Philip O. Livingston, Dick J. Schol, Silvia von Mensdorff-Pouilly, Gerard J. van Kamp
Publikováno v:
International Journal of Cancer. 86:702-712
Antibodies (Abs) to MUC1 occur naturally in both healthy subjects and cancer patients and can be induced by MUC1 peptide vaccination. We compared the specificity of natural and induced MUC1 Abs with the objective of defining an effective MUC1 vaccine
Autor:
Phil D. Rye, P. Seguin, D L Very, M. Leinimaa, W.J. Allard, Robert L. Wolfert, L. Bellanger, I Andersson, L. Lauren, P.C. Ng, K. Nustad, O. Nilsson, Charlotte Becker, Barry L. Dowell, G. Davis, T.R. Barnett, Mavanur R. Suresh, J. Slota, B Karlsson, Ingrid Wigheden, Timo Piironen, Harry G. Rittenhouse, T.J. Wang, M. Nap, Ole P. Børmer, C. Andrés, Kim Pettersson, J. Hilgers, A Peter, J. Rapp, D.C. Jette, Jari Leinonen, Hans Lilja, W-M Zhang, A. Belenky, Zeqi Zhou, F.T. Kreutz, H.J. Linton, T M van der Kwast, U.-H. Stenman, R.L. Sokoloff, Elisabeth Paus, K.K. Yeung, C.M. Pellegrino, L.S. Grauer
Publikováno v:
Tumor Biology. 20:1-12
Twelve research groups participated in the ISOBM TD-3 Workshop in which the reactivity and specificity of 83 antibodies against prostate-specific antigen (PSA) were investigated. Using a variety of techniques including cross-inhibition assays, Wester